Canopy Growth (CGC) Free Cash Flow (2019 - 2025)
Canopy Growth's (CGC) quarterly Free Cash Flow came in at -$13.7 million in Q4 2025, up 32.33% year-on-year from -$10.3 million in Q4 2024, and up 2.18% quarter-over-quarter from -$14.0 million in Q3 2025.
Canopy Growth (CGC) Free Cash Flow (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed Free Cash Flow across 7 years of filings, most recently posting -$13.7 million for Q4 2025.
- Free Cash Flow for Q4 2025 came in at -$13.7 million, up 32.33% year-over-year; the trailing twelve-month figure through Dec 2025 was -$61.3 million (up 22.55% YoY), and the FY2025 annual result was -$123.0 million, up 28.49% from the prior year.
- Free Cash Flow came in at -$13.7 million for Q4 2025 at Canopy Growth, up from -$14.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $23.2 million in Q1 2024 to a low of -$193.6 million in Q1 2023.
- The 5-year median for Free Cash Flow is -$41.0 million (2024), against an average of -$62.5 million.
- Across the five-year window, Free Cash Flow plunged 800.68% in 2023 and surged 111.97% in 2024, its largest moves.
- Canopy Growth's Free Cash Flow stood at -$133.6 million in 2021, then jumped by 85.25% to -$19.7 million in 2022, then slipped by 23.53% to -$24.3 million in 2023, then climbed by 17.11% to -$20.2 million in 2024, then surged by 32.33% to -$13.7 million in 2025.
- The last three Free Cash Flow figures came in at -$13.7 million (Q4 2025), -$14.0 million (Q3 2025), and -$8.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | -13.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13.65 Mn |
| Dec 31, 2025 | -13.65 Mn |
| Sep 30, 2025 | -13.96 Mn |
| Sep 30, 2025 | -13.96 Mn |
| Jun 30, 2025 | -8.40 Mn |
| Jun 30, 2025 | -8.40 Mn |
| Mar 31, 2025 | -25.26 Mn |
| Mar 31, 2025 | -25.26 Mn |
| Dec 31, 2024 | -20.17 Mn |
| Dec 31, 2024 | -20.17 Mn |
| Sep 30, 2024 | -41.37 Mn |
| Sep 30, 2024 | -41.37 Mn |
| Jun 30, 2024 | -40.72 Mn |
| Jun 30, 2024 | -40.72 Mn |
| Mar 31, 2024 | 23.17 Mn |
| Mar 31, 2024 | 23.17 Mn |
| Dec 31, 2023 | -24.34 Mn |
| Dec 31, 2023 | -24.34 Mn |
| Sep 30, 2023 | -59.18 Mn |
| Sep 30, 2023 | -59.18 Mn |